As scientists unravel the ways that genetic inheritance and aging influence the function of a person’s cells, tissues and organs, they are also finding new ways to prevent and treat neurodegenerative diseases. In his Front Row lecture, Scripps Research professor Jeff Kelly will share his research into a broad set of disorders where aberrantly folded proteins lead to degeneration of the heart and/or nervous system. He’ll explain how his research led to the first regulatory agency-approved therapy for these so-called amyloid diseases and how he and his team are developing future precision therapies for Alzheimer’s and Parkinson’s diseases.
ABOUT THE FRONT ROW LECTURE SERIES
Take a seat in the front row and listen as some of the world’s foremost scientists introduce you to the innovative medicines and treatments headed your way from Scripps Research. Each one-hour virtual lecture is free and can be enjoyed from the comfort of your home. Learn more at frontrow.scripps.edu.
ABOUT SCRIPPS RESEARCH
Scripps Research is an independent, nonprofit biomedical institute ranked the most influential in the world for its impact on innovation. With campuses in La Jolla, California, and Jupiter, Florida, we are advancing human health through profound discoveries that address pressing medical concerns around the globe.